American Well (AMWL) Projected to Post Quarterly Earnings on Tuesday

American Well (NYSE:AMWL) is projected to issue its Q3 2026 results after the market closes on Tuesday, November 3rd. Analysts expect American Well to post earnings of ($0.66) per share and revenue of $47.29 million for the quarter. Parties can find conference call details on the company’s upcoming Q3 2026 earnings report page for the latest details on the call scheduled for Tuesday, November 3, 2026 at 5:00 PM ET.

American Well (NYSE:AMWL) last released its earnings results on Tuesday, August 4th. The company reported ($0.59) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.86) by $0.27. American Well had a negative net margin of 35.75% and a negative return on equity of 30.12%. The firm had revenue of $52.05 million during the quarter, compared to analyst estimates of $49.87 million. On average, analysts expect American Well to post ($2.56) EPS for the current fiscal year and ($1.58) EPS for the next fiscal year.

American Well Stock Down 0.3%

Shares of AMWL opened at $13.53 on Tuesday. The stock has a market cap of $223.86 million, a P/E ratio of -2.84 and a beta of 1.67. The business’s 50 day moving average price is $12.78 and its 200-day moving average price is $8.74. American Well has a 52 week low of $3.71 and a 52 week high of $14.56.

Insider Activity at American Well

In other American Well news, insider Phyllis Gotlib sold 6,677 shares of American Well stock in a transaction on Thursday, October 1st. The stock was sold at an average price of $13.00, for a total value of $86,801.00. Following the completion of the sale, the insider owned 142,504 shares of the company’s stock, valued at approximately $1,852,552. This trade represents a 4.48% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Dmitry Zamansky sold 8,442 shares of American Well stock in a transaction on Thursday, October 1st. The stock was sold at an average price of $13.00, for a total value of $109,746.00. Following the completion of the sale, the insider directly owned 224,178 shares of the company’s stock, valued at approximately $2,914,314. The trade was a 3.63% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 19,457 shares of company stock worth $248,519 over the last ninety days. 12.84% of the stock is currently owned by insiders.

Analysts Set New Price Targets

AMWL has been the subject of a number of recent research reports. Weiss Ratings reiterated a “sell (d-)” rating on shares of American Well in a research note on Thursday, October 15th. Needham & Company LLC reissued a “hold” rating on shares of American Well in a report on Wednesday, August 5th. Truist Financial set a $12.00 target price on American Well and gave the stock a “hold” rating in a research note on Thursday, August 13th. Finally, Wells Fargo & Company raised their price target on American Well from $9.00 to $16.00 and gave the company an “overweight” rating in a report on Friday, July 17th. One analyst has rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $9.50.

About American Well

American Well, doing business as Amwell, is a digital healthcare company that provides technology and services for virtual care. Its platform connects patients with healthcare professionals through video and other digital channels, supporting services such as urgent care, behavioral health, primary care and specialty consultations.

Amwell primarily serves health systems, health plans, employers and other healthcare organizations. Its offerings include the Amwell Converge platform, which is designed to help organizations develop, manage and integrate digital care programs with existing clinical workflows and healthcare systems.

Founded in 2006 by brothers Ido and Roy Schoenberg, the company was formerly known as American Well and adopted the Amwell brand in 2020.